Referencias

De Infecto Wiki
  1. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th Edition 2015.
  2. Cohen, Infectious Diseases, 4th edition 2017.
  3. The Jhons Hopkins POC-IT ABX Guide (App).
  4. Sanford Guide Antimicrobial Therapy (App).
  5. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
  6. Scheer CS, et al., Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: a prospective clinical cohort study, Clinical Microbiology and Infection (2018), https://doi.org/10.1016/j.cmi.2018.05.016
  7. Riedel S et al. Timing of specimen collection for blood cultures from febrile patients with bacteremia. J Clin Microbiol. 2008 Apr;46(4):1381-5. doi:10.1128/JCM.02033-07.
  8. Norberg A et al. Contamination rates of blood cultures obtained by dedicated phlebotomy vs intravenous catheter. JAMA. 2003 Feb 12;289(6):726-9.
  9. Mermel L et al. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Jul 1;49(1):1-45. doi: 10.1086/599376.
  10. Chaves F et al. Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensiva. 2018 Jan - Feb;42(1):5-36. doi: 10.1016/j.medin.2017.09.012.
  11. Holland TL et al. Clinical Management of Staphylococcus aureus Bacteremia A Review. JAMA. 2014 Oct 1;312(13):1330 -41. doi:10.1001/jama.2014.9743.
  12. Weis S et al. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteremia: a systematic review and meta- analysis, Clinical Microbiology and Infection, https://doi.org/10.1016/j.cmi.2019.03.010.
  13. Harris PNA et al. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163.
  14. Gutiérrez-Gutiérrez B et al. Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. Clin Microbiol Infect. 2019 Aug;25(8):932-942. doi: 10.1016/j.cmi.2019.03.030.
  15. Durante-Mangoni E et al. Management of carbapenem-resistant Enterobacteriaceae infections. Clin Microbiol Infect. 2019 Aug;25(8):943-950. doi:10.1016/j.cmi.2019.04.013.
  16. Tsuji BT et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019 Jan;39(1):10-39. doi:10.1002/phar.2209.
  17. Yahav D et al. Seven versus fourteen Days of Antibiotic Therapy for uncomplicated Gram-negative Bacteremia: a Non-inferiority Randomized Controlled Trial. Clin Infect Dis. 2018 Dec 11. doi: 10.1093/cid/ciy1054.
  18. Chotiprasitsakul D et al. Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged- Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort. Clin Infect Dis. 2018 Jan 6;66(2):172-177. doi: 10.1093/cid/cix767.
  19. Canzoneri C et al. Follow-up Blood Cultures in Gram-Negative Bacteremia: Are They Needed?. Clin Infect Dis 2017 Nov 13;65 (11):1776-1779. Doi:10.1093/cid/cix648.
  20. Pappas P et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb 15;62(4):409-17. doi: 10.1093/cid/civ1194.
  21. Cornely OA et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: non -neutropenic adult patients. Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37. doi: 10.1111/1469-0691.12039.
  22. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska- Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015 Nov 21;36(44):3075-3128. doi: 10.1093/eurheartj/ehv319. Epub 2015 Aug 29. PMID: 26320109.
  23. Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston PM 3rd, Petermann GW, Osmon DR, Infectious Diseases Society of America. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis. 2015 Sep 15;61(6):e26-46. doi: 10.1093/cid/civ482. Epub 2015 Jul 29. PMID: 26229122.
  24. Depypere M et al., Pathogenesis and management of fracture-related infection, Clinical Microbiology and Infection, https://doi.org/10.1016/j.cmi.2019.08.006
  25. Willem-Jan Metsemakers, Charalampos Zalavras. What is the most optimal prophylaxtic antibiotic coverage and treatment duration for o pen fractures of long bones?. https://icmphilly.com/questions/what-is-the-most-optimal-prophylaxtic-antibiotic-coverage-and-treatment-duration- for-open-fractures-of-long-bones/
  26. Metlay J et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67.
  27. Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016 Sep 10;36(5):481 -508. doi: 10.3747/pdi.2016.00078. Epub 2016 Jun 9. Erratum in: Perit Dial Int. 2018 Jul-Aug;38(4):313. PMID: 27282851; PMCID: PMC5033625.
  28. Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022 Mar;42(2):110- 153. doi: 10.1177/08968608221080586. Erratum in: Perit Dial Int. 2023 May;43(3):279. PMID: 35264029.
  29. Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, Wilcox MH. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021 Jun 24:ciab549. doi: 10.1093/cid/ciab549. Epub ahead of print. PMID: 34164674.
  30. Tamma PD et al. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis. 2021 Apr 8;72(7):e169-e183. doi: 10.1093/cid/ciaa1478.
  31. Orientación técnica para el uso de antibióticos en infecciones comunitarias de manejo ambulatorio. MINSAL. Subsecretaría de Salud Pública. División de Prevención y Control de Enfermedades. Departamento de Enfermedades Transmisibles. Disponible en: https://diprece.minsal.cl › uploads › 2021/10
  32. Curry A, Williams T, Penny ML. Pelvic Inflammatory Disease: Diagnosis, Management, and Prevention. Am Fam Physician. 2019 Sep 15;100(6):357-364. PMID: 31524362.
  33. Norma de Profilaxis, Diagnóstico y Tratamiento de las Infecciones de Transmisión Sexual (ITS). Ministerio de Salud. Norma General Técnica No187 aprobada por Resolución Exenta No484 del 20 de Mayo 2016.
  34. Freifeld A et al. Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.
  35. Heinz WJ et al. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2017 Nov;96(11):1775- 1792. doi: 10.1007/s00277-017-3098-3. Epub 2017 Aug 30.
  36. Taplitz R et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018 Sep 4:JCO1800374. doi: 10.1200/JCO.18.00374.
  37. Taplitz R et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018 May 10;36(14):1443-1453. doi: 10.1200/JCO.2017.77.6211. Epub 2018 Feb 20
  38. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new
  39. https://www.eacsociety.org/guidelines/eacs-guidelines/
  40. Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036. PMID: 32191793.
  41. Gálvez R, Luengo C, Cornejo R, Kosche J, Romero C, Tobar E, Illanes V, Llanos O, Castro J. Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity. Int J Antimicrob Agents. 2011 Aug;38(2):146-51. doi: 10.1016/j.ijantimicag.2011.03.022. Epub 2011 May 25. PMID: 21612894.
  42. Mahmoudi L, Mohammadpour AH, Ahmadi A, Niknam R, Mojtahedzadeh M. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients. Eur Rev Med Pharmacol Sci. 2013 Feb;17(3):285-91. PMID: 23426530.
  43. Duszynska W, Taccone FS, Hurkacz M, Kowalska-Krochmal B, Wiela-Hojeńska A, Kübler A. Therapeutic drug monitoring of amikacin in septic patients. Crit Care. 2013 Jul 25;17(4):R165. doi: 10.1186/cc12844. PMID: 23886243; PMCID: PMC4057344.
  44. Matías Allendes, O. Álvarez, M. Arias, JP Carrasco, M. Darlic, N. Flores, R. Hernández, P. Impellizeri, A. Llanos, C. Paredes, I. Sánchez, G. Valenzuela. Ajuste de dosis de medicamentos en poblaciones especiales. División de Farmacia Clínica SOCHIMI
Obtenido de «https://infectowiki.com/wiki/Referencias?oldid=653»